Agenda Clinical Hematology & Oncology 2025
Friday, February 14, 2025
5-7 p.m.
Welcome Dinner
Join us in the Del Mar breakout room for a complimentary dinner
Saturday, February 15, 2025
7 a.m.
Registration, Breakfast & View Exhibits
7:55 a.m.
Welcome & Educational Overview
8 a.m.
Peri-operative Thrombocytopenia
8:30 a.m.
Hormonal Therapy and Thrombosis Risk
9 a.m.
Barely Abnormal CBCs
9:30 a.m.
Panel Discussion/Q&A
10 a.m.
Break & View Exhibits
10:15 a.m.
Antiphospholipid Syndrome: 2024 Update
10:45 a.m.
Hypereosinophilic Syndrome
11:15 a.m.
Investigating Bleeding of an Obscure Cause
11:45 a.m.
Panel Discussion/Q&A
12 p.m.
Lunch
1 p.m.
What’s New in AML
1:30 p.m.
Should Patients Still Undergo BMT for Myeloma?
2 p.m.
Evolving Therapeutic Approaches in Patients with Low-risk MDS
2:30 p.m.
Panel Discussion/Q&A
2:45 p.m.
Break & View Exhibits
3:15 p.m.
Clinical Ipdates in B-ALL
3:45 p.m.
Refractory Diffuse Large Cell Lymphoma
4:15 p.m.
HLH and HLH-like Inflammatory Syndromes
4:45 p.m.
Panel Discussion/Q&A
CONCURRENT BREAKOUT SESSIONS
5:15 p.m.
Breakout #1: Interesting Cases in Thrombosis
Breakout #2: Interesting Cases in Platelet Disorders
Breakout #3: Interesting Cases in Bleeding
Breakout #4: Interesting Cases in Plasma Cell Dyscrasias
6:15 p.m.
Adjourn
Sunday, February 16, 2025
7 a.m.
Breakfast & View Exhibits
7:55 a.m.
Welcome & Announcements
8 a.m.
Ultra Low Her2 Breast Cancer: Pushing the Boundary in IHC 0 and Treatment Implications
8:30 a.m.
Changing Landscape of Sequencing in HR Positive, Her2 Negative Metastatic Breast Cancer
9 a.m.
Sequencing Therapies in Early Triple Negative Breast Cancer
9:30 a.m.
Panel Discussion/Q&A
10 a.m.
Break & View Exhibits
10:30 a.m.
Neoadjuvant and Adjuvant Therapy for Melanoma
11 a.m.
Management of Variant Histology Renal Cell Carcinoma
11:30 a.m.
Targeted Therapies in Central Nervous System Metastasis
Noon
Panel Discussion/Q&A
12:30 p.m.
Lunch
1:30 p.m.
Rectal Cancer – Making Sense of TNT, ctDNA, and Surgery: A Case-based, Multidisciplinary Discussion
3:30 p.m.
Panel Discussion/Q&A
3:30 p.m.
Break & View Exhibits
4 p.m.
New Targeted Therapies for Gastroesophageal Cancer
4:30 p.m.
TBD
5 p.m.
Panel Discussion/Q&A
5:30 p.m.
Adjourn
Monday, February 17, 2025
7 a.m.
Breakfast & View Exhibits
7:55 a.m.
Welcome & Announcements
8 a.m.
Role of Immune Therapy in Advanced Endometrial Cancer
8:30 a.m.
Updates in the Treatment of Metastatic Soft Tissue Sarcoma
9 a.m.
Genomic Risk Stratification and High Sensitivity Imaging in Localized Prostate Cancer
9:30 a.m.
Panel Discussion/Q&A
10 a.m.
Break & View Exhibits
10:30 a.m.
Optimal Management of ALK Rearranged NSCLC
11 a.m.
Evidence-Based Management of Hormone Deprivation Symptoms After Cancer
11:30 a.m.
Management of Common Skin-related Side Effects of Cancer Treatment
Noon
Panel Discussion/Q&A
12:30 p.m.
Final Adjournment
Please note: All times are listed in Pacific Time (PT). Topics, times and speakers are subject to change.